Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)

Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed-methods approach

(2020) Wei Shen Tan et al.   BJU INTERNATIONAL

Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis

(2020) Han Yang et al.   UROLOGIA INTERNATIONALIS

A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables

(2020) Makito Miyake et al.   International Journal of Clinical Oncology

Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision

(2020) Hiroaki Matsumoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for non-muscle invasive bladder cancer: short-term oncological and functional outcomes

(2020) Makito Miyake et al.   JOURNAL OF ENDOUROLOGY

Efficacy of immediate postoperative instillation of chemotherapy for primary non-muscle invasive bladder cancer in real-world clinical practice

(2019) Kaoru Murakami et al.   Clinical Genitourinary Cancer

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Practice pattern of non‐muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web‐based survey

(2019) Seol Ho Choo et al.   INTERNATIONAL JOURNAL OF UROLOGY

Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation

(2018) Ryuta Tanimoto et al.   WORLD JOURNAL OF UROLOGY

Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan

(2018) Yoshio Naya et al.   MEDICINE

Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort

(2017) Makito Miyake et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

En Bloc Transurethral Resection of Bladder Tumors: A New Standard?

(2017) Angelo Naselli et al.   JOURNAL OF ENDOUROLOGY

Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer

(2016) Alexander I. Rolevich et al.   WORLD JOURNAL OF UROLOGY

Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute

(2015) Makito Miyake et al.   INTERNATIONAL JOURNAL OF UROLOGY

En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial

(2014) Xu Chen et al.   WORLD JOURNAL OF UROLOGY

Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

(2013) Maximilian Burger et al.   EUROPEAN UROLOGY

Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?

(2011) Bogdan Geavlete et al.   BJU INTERNATIONAL

Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor

(2010) Rinzo Ukai et al.   INTERNATIONAL JOURNAL OF UROLOGY

Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer

(2009) Makito Miyake et al.   CANCER SCIENCE

Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies

(2009) Ingo Kausch et al.   EUROPEAN UROLOGY

Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men

(2009) P. Abrams et al.   JOURNAL OF UROLOGY